EquityFlow
›
Companies
› Valanx
Valanx
Biotech
· Klosterneuburg, AT
Defined protein-drug conjugates for pharma
Funding history
Date
Round
Amount
Nov 2023
Seed
Austrian biotech Valanx raised EUR 2.3M (equity and public funding) from SkyGene, xista science ventures, tecnet equity and SOSV.
$2.5M
Investors
SOSV
SkyGene
tecnet equity
xista science ventures
Similar companies in Biotech
Imperagen
Haga Bioscience
Pixelgen Technologies
Gallant
Chai Discovery
SNIPR Biome
Cellbox Labs
Scope Biosciences
GenLumina
Actithera
NUCLIDIUM
Anocca
Explore funding flow on EquityFlow →